{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:11:46Z","timestamp":1790014306138,"version":"4.0.1"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH\/NIDCD","award":["R01DC020299-01A1"],"award-info":[{"award-number":["R01DC020299-01A1"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Cisplatin, a life-saving chemotherapeutic drug, causes ototoxicity. Although sodium thiosulfate is used to prevent ototoxicity in pediatric patients, no other intervention has been approved for clinical use against cisplatin-induced hearing loss. Hence, there is an urgent need to identify drugs that prevent cisplatin ototoxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>CBA\/J mice were treated with cisplatin (3 mg\/kg, i.p., daily for 5 days), and MnTBAP (10 mg\/kg, i.p., daily for 8 days) was used to inhibit cisplatin-induced ototoxicity. Auditory brainstem responses (ABRs) and distortion product otoacoustic emissions (DPOAEs) were recorded before and after treatment to assess hearing loss, while immunohistochemistry with anti-Myosin-VIIa was conducted to examine hair cell loss, with phalloidin to examine spiral ganglion neuron (SGN) loss, and with anti-nitrotyrosine to assess nitrotyrosine levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Cisplatin treatment elevated the nitrotyrosine levels in hair cells and SGNs and increased the loss of these cells in the middle and basal cochlear regions. A negative correlation was observed between cisplatin-induced changes in the hair cell count or SGN density and nitrotyrosine levels. Cisplatin treatment elevated the hearing thresholds, as indicated by the ABRs, and lowered the DPOAE amplitudes, suggesting cisplatin-induced hearing loss. However, MnTBAP cotreatment prevented the cisplatin-induced changes in hearing sensitivity and reversed the morphological changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The otoprotection observed with MnTBAP cotreatment along with the attenuation of cisplatin-induced increase in nitrotyrosine levels in the cochlea indicates its potential as an inhibitor of cochlear nitrative stress and its utility in mitigating cisplatin-induced ototoxicity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0351911","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:39:45Z","timestamp":1790012385000},"page":"e0351911","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Otoprotective effect of MnTBAP in cisplatin-induced hearing loss"],"prefix":"10.1371","volume":"21","author":[{"given":"Shomaila","family":"Mehmood","sequence":"first","affiliation":[{"name":"Institute of Environmental Health Sciences, Wayne State University","place":["Detroit, Michigan, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0835-3578","authenticated-orcid":true,"given":"Pankaj","family":"Bhatia","sequence":"additional","affiliation":[{"name":"Institute of Environmental Health Sciences, Wayne State University","place":["Detroit, Michigan, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5269-9007","authenticated-orcid":true,"given":"Samson","family":"Jamesdaniel","sequence":"additional","affiliation":[{"name":"Institute of Environmental Health Sciences, Wayne State University","place":["Detroit, Michigan, United States of America"]},{"name":"Wayne State University","place":["Detroit, Michigan, United States of America"],"department":["Department of Family Medicine and Public Health Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"issue":"11","key":"pone.0351911.ref001","first-page":"509","article-title":"Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects","volume":"1","author":"JH Hohnloser","year":"1996","journal-title":"Eur J Med Res"},{"key":"pone.0351911.ref002","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1757-2215-2-2","article-title":"Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role","volume":"2","author":"CW Helm","year":"2009","journal-title":"J Ovarian Res"},{"issue":"8","key":"pone.0351911.ref003","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.tips.2013.05.006","article-title":"Understanding platinum-induced ototoxicity","volume":"34","author":"T Langer","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"pone.0351911.ref004","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"S Dasari","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"pone.0351911.ref005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00464252","article-title":"Analysis of hearing loss due to cis-diamminedichloroplatinum-II","volume":"239","author":"LG van Zeijl","year":"1984","journal-title":"Arch Otorhinolaryngol"},{"issue":"34","key":"pone.0351911.ref006","doi-asserted-by":"crossref","first-page":"8588","DOI":"10.1200\/JCO.2004.00.5355","article-title":"Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development","volume":"23","author":"KRG Knight","year":"2005","journal-title":"J Clin Oncol"},{"key":"pone.0351911.ref007","doi-asserted-by":"crossref","first-page":"110401","DOI":"10.1016\/j.ijporl.2020.110401","article-title":"Ototoxicity-induced hearing loss and quality of life in survivors of paediatric cancer","volume":"138","author":"K Rajput","year":"2020","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"3","key":"pone.0351911.ref008","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/pbc.21875","article-title":"Ototoxicity in children treated for osteosarcoma","volume":"52","author":"MJ Lewis","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"pone.0351911.ref009","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hed.23551","article-title":"Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature","volume":"37","author":"EAR Theunissen","year":"2015","journal-title":"Head Neck"},{"key":"pone.0351911.ref010","doi-asserted-by":"crossref","DOI":"10.1080\/14992027.2017.1353710","article-title":"Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients","volume":"57","author":"NC Schmitt","year":"2018","journal-title":"Int J Audiol"},{"key":"pone.0351911.ref011","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.heares.2006.09.015","article-title":"Mechanisms of cisplatin-induced ototoxicity and prevention","volume":"226","author":"LP Rybak","year":"2007","journal-title":"Hear Res"},{"key":"pone.0351911.ref012","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijporl.2016.09.001","article-title":"Analysis of genetic and non genetic risk factors for cisplatin ototoxicity in pediatric patients","volume":"90","author":"Y Olgun","year":"2016","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"4","key":"pone.0351911.ref013","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0196-0709(86)80050-3","article-title":"Cisplatin: evaluation of its ototoxic potential","volume":"7","author":"M Anniko","year":"1986","journal-title":"Am J Otolaryngol"},{"key":"pone.0351911.ref014","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0378-5955(98)00116-6","article-title":"A semiquantitative analysis of the effects of cisplatin on the rat stria vascularis","volume":"124","author":"RP Meech","year":"1998","journal-title":"Hear Res"},{"key":"pone.0351911.ref015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.heares.2004.12.007","article-title":"Immunohistochemical detection of platinated DNA in the cochlea of cisplatin-treated guinea pigs","volume":"203","author":"MWM van Ruijven","year":"2005","journal-title":"Hear Res"},{"issue":"11","key":"pone.0351911.ref016","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/ar.22577","article-title":"Review: ototoxic characteristics of platinum antitumor drugs","volume":"295","author":"D Ding","year":"2012","journal-title":"Anat Rec (Hoboken)"},{"key":"pone.0351911.ref017","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1044\/2021_AJA-21-00006","article-title":"Mechanisms of Aminoglycoside- and Cisplatin-Induced Ototoxicity","volume":"30","author":"PS Steyger","year":"2021","journal-title":"Am J Audiol"},{"issue":"8","key":"pone.0351911.ref018","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1021\/pr8002479","article-title":"Proteomic analysis of the balance between survival and cell death responses in cisplatin-mediated ototoxicity","volume":"7","author":"S Jamesdaniel","year":"2008","journal-title":"J Proteome Res"},{"key":"pone.0351911.ref019","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.heares.2009.08.001","article-title":"Selective GSK-3beta inhibitors attenuate the cisplatin-induced cytotoxicity of auditory cells","volume":"257","author":"H-J Park","year":"2009","journal-title":"Hear Res"},{"issue":"12","key":"pone.0351911.ref020","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1523\/JNEUROSCI.5842-08.2009","article-title":"Cisplatin-induced hair cell death requires STAT1 and is attenuated by epigallocatechin gallate","volume":"29","author":"NC Schmitt","year":"2009","journal-title":"J Neurosci"},{"issue":"44","key":"pone.0351911.ref021","doi-asserted-by":"crossref","first-page":"46065","DOI":"10.1074\/jbc.M403046200","article-title":"NOX3, a superoxide-generating NADPH oxidase of the inner ear","volume":"279","author":"B B\u00e1nfi","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"pone.0351911.ref022","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuro.2005.05.010","article-title":"Cisplatin ototoxicity to the rat inner ear: a role for HMG1 and iNOS","volume":"27","author":"G Li","year":"2006","journal-title":"Neurotoxicology"},{"key":"pone.0351911.ref023","first-page":"4081","article-title":"Nuclear-factor kappa B (NF-kappa B)-inducible nitric oxide synthase (iNOS\/NOS II) pathway damages the stria vascularis in cisplatin-treated mice","volume":"22","author":"K Watanabe","year":"2002","journal-title":"Anticancer Research"},{"issue":"6","key":"pone.0351911.ref024","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/ph15060649","article-title":"Nitrative Stress and Auditory Dysfunction","volume":"15","author":"M Shahab","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"13","key":"pone.0351911.ref025","doi-asserted-by":"crossref","first-page":"12747","DOI":"10.1074\/jbc.M500175200","article-title":"Modulation of the interleukin-6 receptor subunit glycoprotein 130 complex and its signaling by LMO4 interaction","volume":"280","author":"V Novotny-Diermayr","year":"2005","journal-title":"J Biol Chem"},{"issue":"47","key":"pone.0351911.ref026","doi-asserted-by":"crossref","first-page":"12433","DOI":"10.1523\/JNEUROSCI.2897-08.2008","article-title":"Rescue of neurons from ischemic injury by peroxisome proliferator-activated receptor-gamma requires a novel essential cofactor LMO4","volume":"28","author":"SC Schock","year":"2008","journal-title":"J Neurosci"},{"issue":"4","key":"pone.0351911.ref027","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.bbrc.2006.03.077","article-title":"The tumor suppressor LKB1 induces p21 expression in collaboration with LMO4, GATA-6, and Ldb1","volume":"343","author":"T Setogawa","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"44","key":"pone.0351911.ref028","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1038\/sj.onc.1210465","article-title":"The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells","volume":"26","author":"N Wang","year":"2007","journal-title":"Oncogene"},{"issue":"30","key":"pone.0351911.ref029","doi-asserted-by":"crossref","first-page":"10072","DOI":"10.1523\/JNEUROSCI.0352-14.2014","article-title":"LMO4 functions as a negative regulator of sensory organ formation in the mammalian cochlea","volume":"34","author":"M Deng","year":"2014","journal-title":"J Neurosci"},{"issue":"12","key":"pone.0351911.ref030","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.3390\/antiox10121919","article-title":"Oxidative Stress and Inflammation Caused by Cisplatin Ototoxicity","volume":"10","author":"V Ramkumar","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"pone.0351911.ref031","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3389\/fphar.2020.00999","article-title":"Current Strategies to Combat Cisplatin-Induced Ototoxicity","volume":"11","author":"D Yu","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"pone.0351911.ref032","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1038\/s41598-019-40425-9","article-title":"Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3\/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea","volume":"9","author":"P Bhatta","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"pone.0351911.ref033","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/cr.2011.27","article-title":"Cisplatin ototoxicity involves cytokines and STAT6 signaling network","volume":"21","author":"H-J Kim","year":"2011","journal-title":"Cell Res"},{"issue":"2","key":"pone.0351911.ref034","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ohn.1272","article-title":"N-acetylcysteine for the Prevention of Cisplatin-Induced Hearing Loss: A Systematic Review and Meta-analysis","volume":"173","author":"J Plane","year":"2025","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"18","key":"pone.0351911.ref035","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1200\/JCO.23.02353","article-title":"Use of Sodium Thiosulfate as an Otoprotectant in Patients With Cancer Treated With Platinum Compounds: A Review of the Literature","volume":"42","author":"AJM Meijer","year":"2024","journal-title":"J Clin Oncol"},{"issue":"13","key":"pone.0351911.ref036","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1158\/1078-0432.CCR-23-0252","article-title":"Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial","volume":"29","author":"E Orgel","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"1","key":"pone.0351911.ref037","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40463-019-0327-x","article-title":"A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer","volume":"48","author":"V Rolland","year":"2019","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"1","key":"pone.0351911.ref038","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5935\/0946-5448.20180007","article-title":"Transtympanic Injections of N-acetylcysteine and Dexamethasone for Prevention of Cisplatin-Induced Ototoxicity: Double Blind Randomized Clinical Trial","volume":"22","author":"Z Sarafraz","year":"2018","journal-title":"Int Tinnitus J"},{"issue":"4","key":"pone.0351911.ref039","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00001813-199904000-00011","article-title":"Cisplatin combined with tiopronin or sodium thiosulfate: cytotoxicity in vitro and antitumor activity in vivo","volume":"10","author":"M Viale","year":"1999","journal-title":"Anticancer Drugs"},{"issue":"2","key":"pone.0351911.ref040","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1124\/jpet.104.075119","article-title":"The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway","volume":"312","author":"YJ Wu","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"25","key":"pone.0351911.ref041","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1056\/NEJMoa1801109","article-title":"Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss","volume":"378","author":"PR Brock","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0351911.ref042","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijpharm.2015.08.015","article-title":"Recent advances in local drug delivery to the inner ear","volume":"494","author":"N El Kechai","year":"2015","journal-title":"Int J Pharm"},{"issue":"5","key":"pone.0351911.ref043","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrd4533","article-title":"New treatment options for hearing loss","volume":"14","author":"U M\u00fcller","year":"2015","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"pone.0351911.ref044","article-title":"Medical interventions for the prevention of platinum-induced hearing loss in children with cancer","volume":"5","author":"JW van As","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"pone.0351911.ref045","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.freeradbiomed.2008.09.042","article-title":"Pure MnTBAP selectively scavenges peroxynitrite over superoxide: comparison of pure and commercial MnTBAP samples to MnTE-2-PyP in two models of oxidative stress injury, an SOD-specific Escherichia coli model and carrageenan-induced pleurisy","volume":"46","author":"I Batini\u0107-Haberle","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"pone.0351911.ref046","article-title":"Protective effect of metalloporphyrins against cisplatin-induced kidney injury in mice","volume":"9","author":"H Pan","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"pone.0351911.ref047","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/ana.10684","article-title":"Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy","volume":"54","author":"M Klein","year":"2003","journal-title":"Ann Neurol"},{"key":"pone.0351911.ref048","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.redox.2016.10.016","article-title":"Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity","volume":"10","author":"S Jamesdaniel","year":"2016","journal-title":"Redox Biol"},{"key":"pone.0351911.ref049","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.heares.2019.02.006","article-title":"An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity","volume":"375","author":"K Fernandez","year":"2019","journal-title":"Hear Res"},{"issue":"15","key":"pone.0351911.ref050","first-page":"2923","article-title":"Noise-induced nitrotyrosine increase and outer hair cell death in guinea pig cochlea","volume":"126","author":"W Han","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"pone.0351911.ref051","doi-asserted-by":"crossref","first-page":"761847","DOI":"10.3389\/fcell.2021.761847","article-title":"Generation of a Spiral Ganglion Neuron Degeneration Mouse Model","volume":"9","author":"Z Hu","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"22","key":"pone.0351911.ref052","doi-asserted-by":"crossref","first-page":"18674","DOI":"10.1074\/jbc.M111.297960","article-title":"Cisplatin-induced ototoxicity is mediated by nitroxidative modification of cochlear proteins characterized by nitration of Lmo4","volume":"287","author":"S Jamesdaniel","year":"2012","journal-title":"J Biol Chem"},{"key":"pone.0351911.ref053","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.freeradbiomed.2022.02.003","article-title":"Maintaining homeostasis of mitochondria and endoplasmic reticulum with NSC228155 alleviates cisplatin-induced acute kidney injury","volume":"181","author":"Y Li","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"pone.0351911.ref054","doi-asserted-by":"crossref","first-page":"109022","DOI":"10.1016\/j.heares.2024.109022","article-title":"Quantitative profiling of cochlear synaptosomal proteins in cisplatin-induced synaptic dysfunction","volume":"447","author":"M Shahab","year":"2024","journal-title":"Hear Res"},{"key":"pone.0351911.ref055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0361-9230(03)00047-9","article-title":"Structure and innervation of the cochlea","volume":"60","author":"Y Raphael","year":"2003","journal-title":"Brain Res Bull"},{"key":"pone.0351911.ref056","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.heares.2013.01.008","article-title":"Lead roles for supporting actors: critical functions of inner ear supporting cells","volume":"303","author":"EL Monzack","year":"2013","journal-title":"Hear Res"},{"issue":"2","key":"pone.0351911.ref057","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1021\/ar300234c","article-title":"Protein tyrosine nitration: biochemical mechanisms and structural basis of functional effects","volume":"46","author":"R Radi","year":"2013","journal-title":"Acc Chem Res"},{"issue":"4","key":"pone.0351911.ref058","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.freeradbiomed.2008.04.010","article-title":"Protein tyrosine nitration--functional alteration or just a biomarker?","volume":"45","author":"JM Souza","year":"2008","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"pone.0351911.ref059","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s12035-020-02226-4","article-title":"Lmo4 Deficiency Enhances Susceptibility to Cisplatin-Induced Cochlear Apoptosis and Hearing Loss","volume":"58","author":"R Rosati","year":"2021","journal-title":"Mol Neurobiol"},{"key":"pone.0351911.ref060","doi-asserted-by":"crossref","first-page":"100241","DOI":"10.1016\/j.crtox.2025.100241","article-title":"Differential effect of targeting cisplatin-induced nitrative stress using MnTBAP in auditory and cancer cells","volume":"8","author":"S Mehmood","year":"2025","journal-title":"Curr Res Toxicol"},{"key":"pone.0351911.ref061","doi-asserted-by":"crossref","first-page":"101967","DOI":"10.1016\/j.toxrep.2025.101967","article-title":"MnTBAP, a peroxynitrite scavenger, attenuates cisplatin-induced apoptosis and cytotoxicity in organ of Corti cells","volume":"14","author":"M Shahab","year":"2025","journal-title":"Toxicol Rep"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0351911","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:39:55Z","timestamp":1790012395000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0351911"}},"subtitle":[],"editor":[{"given":"Pavle","family":"Randjelovic","sequence":"first","affiliation":[{"name":"University of Nis Faculty of Medicine: Univerzitet u Nisu Medicinski Fakultet","place":["SERBIA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":61,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0351911","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}